MESSINA, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.474
EU - Europa 672
AS - Asia 299
SA - Sud America 13
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.471
Nazione #
US - Stati Uniti d'America 1.461
SE - Svezia 266
IT - Italia 235
SG - Singapore 149
CN - Cina 73
IN - India 66
FI - Finlandia 54
DE - Germania 46
BG - Bulgaria 19
CA - Canada 12
RO - Romania 12
UA - Ucraina 11
AR - Argentina 9
GB - Regno Unito 8
TG - Togo 8
NL - Olanda 7
ID - Indonesia 5
BR - Brasile 4
FR - Francia 4
ES - Italia 3
IE - Irlanda 3
ZA - Sudafrica 3
IL - Israele 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BE - Belgio 1
CZ - Repubblica Ceca 1
EU - Europa 1
MK - Macedonia 1
MX - Messico 1
PK - Pakistan 1
Totale 2.471
Città #
Fairfield 255
Ashburn 153
Singapore 118
Seattle 101
Woodbridge 92
Chandler 88
Rome 84
Stockholm 82
Wilmington 76
Houston 75
Cambridge 70
Ann Arbor 53
Santa Clara 45
Princeton 39
Dearborn 35
Plano 30
Helsinki 28
Bremen 22
Millbury 21
San Diego 21
San Paolo di Civitate 21
Sofia 19
Beijing 18
New York 17
Lawrence 16
Boston 14
Florence 13
Andover 12
Des Moines 11
Milan 11
Toronto 10
Lomé 8
Cagliari 7
Buenos Aires 5
Jakarta 5
Mannheim 5
Federal 4
Hefei 4
Boardman 3
Dublin 3
Falls Church 3
Genoa 3
Jacksonville 3
Kunming 3
Nanjing 3
Norwalk 3
Palermo 3
Pune 3
Redwood City 3
Shenyang 3
Turin 3
Bari 2
Bologna 2
Bühl 2
Calolziocorte 2
Cape Town 2
Fremont 2
Fuzhou 2
Genazzano 2
Guangzhou 2
Guarulhos 2
Indiana 2
Lappeenranta 2
Lido di Ostia 2
Los Angeles 2
Madrid 2
Naples 2
Ningbo 2
Ottawa 2
Porto Alegre 2
Redmond 2
Southend 2
Vicenza 2
Vittuone 2
Aprilia 1
Arnsberg 1
Atlanta 1
Bolzano Vicentino 1
Brussels 1
Casalnuovo di Napoli 1
Cesena 1
Changsha 1
Chengdu 1
Chicago 1
Ciampino 1
Coominya 1
Council Bluffs 1
Dubai 1
Falkenstein 1
Formia 1
Giussano 1
Gostivar 1
Gurgaon 1
Haifa 1
Islamabad 1
Jinan 1
Kumar 1
Livorno 1
London 1
Mcallen 1
Totale 1.799
Nome #
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial 104
Critical role of c-Myc in acute myeloid leukemia involving direct regulation of miR-26a and histone methyltransferase EZH2 97
A case of late isolated ovarian relapse of acute lymphoblastic leukemia after an allogeneic stem cell transplant. 95
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes 90
Gene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223 85
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. 84
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial 82
Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis. 78
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes. 78
IgD cross-linking induces gene expression profiling changes and enhances apoptosis in chronic lymphocytic leukemia cells 77
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib 77
Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia 77
SQSTM1-NUP214: a new gene fusion in adult T-cell acute lymphoblastic leukemia 74
Minimal residual disease in acute lymphoblastic leukemia: technical and clinical advances 73
Characterization of B- and T-Lineage Acute Lymphoblastic Leukemia by Integrated Analysis of MicroRNA and mRNA Expression Profiles 72
Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis 71
Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia 71
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications 69
null 68
NOTCH1, SF3B1 and BIRC3 Mutations in Chronic Lymphocytic Leukemia (CLL) Patients Requiring First-LINE Treatment: Correlation with Biological Parameters and Response to Treatment 65
null 62
null 60
null 58
null 58
Blast morphology in the diagnostic work-up of Ph-like acute lymphoblastic leukemia 57
null 54
null 53
null 53
null 49
The Addition of Venetoclax to Induction Chemotherapy in No Low-Risk AML Patients: A Propensity Score-Matched Analysis of the Gimema AML1718 and AML1310 Trials 48
NOTCH1, SF3B1, BIRC3 AND TP53 mutations in chronic lymphocytic leukemia patients undergoing first-line treatment: correlation with biological parameters and response to treatment. 48
null 47
GENETIC DETERMINANTS OF FLUDARABINE-RESISTANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 41
P523: The comparison of VFLAI, FLAI and 3 + 7 regimens by multilevel propensity score weighting highlights the benefit of the addition of venetoclax in no low risk aml treated in Gimema trials real world 39
Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia 39
Chronic lymphocytic leukemia cells from paired lymph node and peripheral blood show a different pattern of copy number aberrations 38
STUDIO DEL PROFILO DI ESPRESSIONE GENICA DELLA LEUCEMIA ACUTA LINFOBLASTICA DELL'ADULTO 33
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996 31
P495: UNLOCKING THE POTENTIAL OF SYNTHETIC PATIENTS FOR ACCELERATING CLINICAL TRIALS: RESULTS OF THE FIRST GIMEMA EXPERIENCE 28
Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients 24
High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangement 21
BCR/ABL1–like acute lymphoblastic leukemia: How to diagnose and treat? 20
Prognostic implications of additional genomic lesions in adult Ph+ acute lymphoblastic leukemia 20
IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies 19
Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments 17
Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212. 11
Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts 11
The genetics of nodal marginal zone lymphoma 8
Totale 2.634
Categoria #
all - tutte 7.692
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.692


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020336 0 0 0 0 0 79 79 58 60 29 18 13
2020/2021143 21 16 7 6 2 4 2 17 18 27 18 5
2021/2022479 7 18 21 80 51 10 5 31 35 39 107 75
2022/2023425 77 81 47 40 36 51 2 44 24 5 14 4
2023/2024298 10 35 13 30 24 70 10 39 0 27 19 21
2024/2025354 75 105 44 68 47 15 0 0 0 0 0 0
Totale 2.634